Glenmark Generics Ltd.
Records under this name other than patents Glenmark Generics Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Glenmark Generics Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,097,729 | Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,227,958 | Amorphous and crystalline forms of aprepitant and processes for the preparation thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,550,735 | Process for the preparation of ivacaftor and solvates thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,840,456 | Process for preparation of dimethyl fumarate Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,312,329 | Process for the preparation of pyrimidine derivatives Formerly held Term ended Term ended Aug 14, 2026 · From the USPTO record | Term ended | Term ended Aug 14, 2026 | From the USPTO record |
| US 8,673,356 | Stable fixed dose topical formulation Formerly held Lapsed on the fee record Ended Mar 18, 2026 · From the USPTO record | Lapsed on the fee record | Ended Mar 18, 2026 | From the USPTO record |
| US 8,623,844 | Fosaprepitant dimeglumine intermediate, neutral fosaprepitant, and amorphous fosaprepitant dimeglumine and processes for their preparations Formerly held Lapsed on the fee record Ended Jan 7, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 7, 2026 | From the USPTO record |
| US 9,518,048 | Process for the preparation of teneligliptin Formerly held Lapsed on the fee record Ended Dec 13, 2024 · From the USPTO record | Lapsed on the fee record | Ended Dec 13, 2024 | From the USPTO record |
| US 9,499,475 | Process for the preparation of arformoterol or salt thereof Formerly held Lapsed on the fee record Ended Nov 22, 2024 · From the USPTO record | Lapsed on the fee record | Ended Nov 22, 2024 | From the USPTO record |
| US 8,304,544 | Palonosetron free base and process for its preparation Formerly held Lapsed on the fee record Ended Nov 6, 2024 · From the USPTO record | Lapsed on the fee record | Ended Nov 6, 2024 | From the USPTO record |